Tocqueville Asset Management’s Sangamo Therapeutics SGMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-14,380
| Closed | -$7.81K | – | 552 |
|
|
2023
Q4 | $7.81K | Sell |
14,380
-400
| -3% | -$217 | ﹤0.01% | 516 |
|
|
2023
Q3 | $8.87K | Hold |
14,780
| – | – | ﹤0.01% | 511 |
|
|
2023
Q2 | $19.2K | Sell |
14,780
-2,800
| -16% | -$3.64K | ﹤0.01% | 533 |
|
|
2023
Q1 | $30.9K | Hold |
17,580
| – | – | ﹤0.01% | 526 |
|
|
2022
Q4 | $55.2K | Hold |
17,580
| – | – | ﹤0.01% | 569 |
|
|
2022
Q3 | $86K | Hold |
17,580
| – | – | ﹤0.01% | 584 |
|
|
2022
Q2 | $73K | Sell |
17,580
-2,000
| -10% | -$8.31K | ﹤0.01% | 652 |
|
|
2022
Q1 | $114K | Hold |
19,580
| – | – | ﹤0.01% | 690 |
|
|
2021
Q4 | $147K | Sell |
19,580
-5,000
| -20% | -$37.5K | ﹤0.01% | 721 |
|
|
2021
Q3 | $221K | Sell |
24,580
-1,240
| -5% | -$11.1K | ﹤0.01% | 689 |
|
|
2021
Q2 | $309K | Sell |
25,820
-270
| -1% | -$3.23K | ﹤0.01% | 631 |
|
|
2021
Q1 | $327K | Sell |
26,090
-150
| -0.6% | -$1.88K | 0.01% | 625 |
|
|
2020
Q4 | $409K | Sell |
26,240
-11,200
| -30% | -$175K | 0.01% | 571 |
|
|
2020
Q3 | $354K | Sell |
37,440
-1,200
| -3% | -$11.3K | 0.01% | 549 |
|
|
2020
Q2 | $346K | Sell |
38,640
-91,115
| -70% | -$816K | 0.01% | 543 |
|
|
2020
Q1 | $827K | Sell |
129,755
-5,180
| -4% | -$33K | 0.02% | 382 |
|
|
2019
Q4 | $1.13M | Buy |
134,935
+61,945
| +85% | +$518K | 0.02% | 437 |
|
|
2019
Q3 | $661K | Sell |
72,990
-68,747
| -49% | -$623K | 0.01% | 511 |
|
|
2019
Q2 | $1.53M | Buy |
141,737
+600
| +0.4% | +$6.46K | 0.02% | 418 |
|
|
2019
Q1 | $1.35M | Buy |
141,137
+22,100
| +19% | +$211K | 0.02% | 434 |
|
|
2018
Q4 | $1.37M | Sell |
119,037
-592,200
| -83% | -$6.8M | 0.02% | 422 |
|
|
2018
Q3 | $12.1M | Buy |
711,237
+370,297
| +109% | +$6.28M | 0.15% | 173 |
|
|
2018
Q2 | $4.84M | Buy |
340,940
+30,700
| +10% | +$436K | 0.06% | 306 |
|
|
2018
Q1 | $5.9M | Sell |
310,240
-355,650
| -53% | -$6.76M | 0.08% | 276 |
|
|
2017
Q4 | $10.9M | Buy |
665,890
+341,075
| +105% | +$5.59M | 0.12% | 196 |
|
|
2017
Q3 | $4.87M | Sell |
324,815
-30,200
| -9% | -$453K | 0.06% | 321 |
|
|
2017
Q2 | $3.12M | Sell |
355,015
-35,900
| -9% | -$316K | 0.04% | 366 |
|
|
2017
Q1 | $2.03M | Buy |
390,915
+143,250
| +58% | +$745K | 0.02% | 419 |
|
|
2016
Q4 | $755K | Buy |
247,665
+40,300
| +19% | +$123K | 0.01% | 530 |
|
|
2016
Q3 | $960K | Sell |
207,365
-81,975
| -28% | -$380K | 0.01% | 513 |
|
|
2016
Q2 | $1.68M | Sell |
289,340
-10,175
| -3% | -$58.9K | 0.02% | 442 |
|
|
2016
Q1 | $1.81M | Sell |
299,515
-4,050
| -1% | -$24.5K | 0.02% | 415 |
|
|
2015
Q4 | $2.77M | Sell |
303,565
-1,435
| -0.5% | -$13.1K | 0.04% | 371 |
|
|
2015
Q3 | $1.72M | Sell |
305,000
-156,620
| -34% | -$883K | 0.02% | 466 |
|
|
2015
Q2 | $5.12M | Buy |
461,620
+17,020
| +4% | +$189K | 0.06% | 307 |
|
|
2015
Q1 | $6.97M | Buy |
444,600
+370,800
| +502% | +$5.81M | 0.08% | 264 |
|
|
2014
Q4 | $1.12M | Buy |
73,800
+25,000
| +51% | +$380K | 0.01% | 559 |
|
|
2014
Q3 | $526K | Sell |
48,800
-9,000
| -16% | -$97K | 0.01% | 607 |
|
|
2014
Q2 | $883K | Buy |
57,800
+10,900
| +23% | +$167K | 0.01% | 606 |
|
|
2014
Q1 | $848K | Buy |
46,900
+16,900
| +56% | +$306K | 0.01% | 479 |
|
|
2013
Q4 | $417K | Hold |
30,000
| – | – | 0.01% | 620 |
|
|
2013
Q3 | $315K | Buy |
30,000
+10,000
| +50% | +$105K | ﹤0.01% | 759 |
|
|
2013
Q2 | $156K | Buy |
+20,000
| New | +$156K | ﹤0.01% | 884 |
|